½ÃÀ庸°í¼­
»óǰÄÚµå
1401407

¼¼°èÀÇ ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°º°, ±â¼úº°, ¿öÅ©Ç÷ο캰, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Long Read Sequencing Market Size study & Forecast, by Product, by Technology, by Workflow, by Application, by End use, and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ·Õ¸®µå ½ÃÄö½Ì ½ÃÀåÀº 2022³â ¾à 4¾ï 5,510¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023³âºÎÅÍ 2030³â±îÁö 30.92% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

·Õ¸®µå ½ÃÄö½Ì ½ÃÀåÀº À¯Àüü ¹× ±âŸ »ý¹°ÇÐÀû ½ÇüÀÇ »ó¼¼ÇÑ ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÏ´Â À¯Àü Á¤º¸ÀÇ È®ÀåµÈ ¿¬¼ÓÀûÀÎ ½ÃÄö½ÌÀ» »ý¼ºÇÒ ¼ö ÀÖ´Â DNA ½ÃÄö½Ì ¹æ¹ý·Ð¿¡ ƯȭµÈ ´Ù¾çÇÑ Á¦Ç°, ¼­ºñ½º ¹× ±â¼úÀ» Æ÷ÇÔÇÕ´Ï´Ù. ·Õ¸®µå ½ÃÄö½Ì Ç÷§Æû, ±â±â, ½Ã¾à ¹× °ü·Ã ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ °³¹ßÀ» Æ÷ÇÔÇϸç, À¯ÀüüÇÐ ¿¬±¸, °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¹× »ý¸í°úÇÐ ºÐ¾ßÀÇ ±âŸ ÀÀ¿ë ºÐ¾ßÀÇ ¹ßÀüÀ» ÃËÁøÇÕ´Ï´Ù. ·Õ¸®µå ½ÃÄö½Ì ½ÃÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÓ»ó Áø´ÜÀÇ ÀÀ¿ë ºÐ¾ß Áõ°¡¿Í °°Àº ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

·Õ¸®µå ½ÃÄö½ÌÀº ´õ ±æ°í ¿¬¼ÓÀûÀÎ DNA ¿°±â¼­¿­À» »ý¼ºÇÏ¿© À¯Àüü¸¦ º¸´Ù Á¤È®ÇÏ°í Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. À̸¦ ÅëÇØ ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, ¾Ï°ú °°Àº ¸¸¼º Áúȯ°ú °ü·ÃµÈ Èñ±Í º¯ÀÌü ¹× ±¸Á¶Àû º¯ÀÌü¸¦ Æ÷ÇÔÇÑ À¯ÀüÀû º¯À̸¦ ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ì±¹½ÉÀåÇùȸ¿¡ µû¸£¸é 2020³â Àü ¼¼°è ´ç´¢º´ À¯º´ÀÚ ¼ö´Â ³²¼º 2¾ï 4,330¸¸ ¸í, ¿©¼º 2¾ï 2,900¸¸ ¸íÀ̸ç, ´ç´¢º´ÀÇ °æÁ¦Àû ºÎ´ãÀº 2015³â 1Á¶ 3,000¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2030³â¿¡´Â 2Á¶ 1,000¾ï ´Þ·¯¿¡¼­ 2Á¶ 5,000¾ï ´Þ·¯·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ±¹Á¦¾Ï¿¬±¸¼Ò(IARC)ÀÇ ÃßÁ¤¿¡ µû¸£¸é, 2021³â 190¸¸ ¸í¿¡ ºÒ°úÇß´ø ¾Ï ¹ßº´ÀÚ°¡ 2020³â¿¡´Â 2,750¸¸ ¸íÀ¸·Î ´Ã¾î³¯ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌó·³ ¸¸¼ºÁúȯÀÇ °æÁ¦Àû ºÎ´ãÀÌ Áõ°¡Çϸ鼭 ·Õ¸®µå ½ÃÄö½Ì ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ ºÐ¼® Ç÷§ÆûÀÇ ¹ßÀü°ú ÀüÀåÀ¯Àüü ½ÃÄö½ÌÀÇ ÀÀ¿ë ºÐ¾ß°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ·Õ¸®µå ±â¼úÀÇ ³ôÀº ¿À·ùÀ²Àº 2023³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â °­·ÂÇÑ Á¤º¸ÇÐ ³×Æ®¿öÅ©ÀÇ °¡¿ë¼º°ú À¯Àüü °Ë»ç Á¦Ç° ¹× ¼­ºñ½ºÀÇ ½ÂÀÎ ¹× ¸¶ÄÉÆÃ¿¡ ´ëÇÑ ±ÔÁ¤ÀÌ È®¸³µÇ¾î ÀÖ¾î 2022³â ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÃÖ÷´Ü Áø´Ü ±â¼ú °³¹ß¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÏ°í ºñÁö´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ·Á´Â ´ë±â¾÷ÀÇ ÀÔÁö°¡ È®´ëµÊ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀ¸·Î °£Áֵ˴ϴÙ.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • ¾÷°èÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå ¿ªÇÐ

  • ·Õ¸®µå ½ÃÄö½Ì ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡
      • ÀÓ»ó Áø´ÜÀÇ ¾ÖÇø®ÄÉÀÌ¼Ç Áõ°¡
    • ½ÃÀå °úÁ¦
      • ·Õ¸®µå ±â¼úÀÇ ³ôÀº ¿¡·¯À²
    • ½ÃÀå ±âȸ
      • µ¥ÀÌÅÍ ºÐ¼® Ç÷§Æû Áøº¸
      • Àü°Ô³ð ½ÃÄö½ÌÀÇ ¾ÖÇø®ÄÉÀ̼ǰú ¼ö¿ä Áõ°¡
      • ±â¼ú Áøº¸ »ó½Â

Á¦4Àå ¼¼°èÀÇ ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : Á¦Ç°º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ±â±â
    • ¼Ò¸ðǰ
    • ¼­ºñ½º

Á¦6Àå ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ±â¼úº°

  • ½ÃÀå ÇöȲ
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ±â¼úº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ±â¼úº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ´ÜÀÏ ºÐÀÚ ½Ç½Ã°£ ½ÃÄö½Ì
    • ³ª³ëÆ÷¾î ½ÃÄö½Ì
    • ±âŸ

Á¦7Àå ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ¿öÅ©Ç÷ο캰

  • ½ÃÀå ÇöȲ
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ¿öÅ©Ç÷ο캰, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ¿öÅ©Ç÷ο캰, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ÇÁ¸® ½ÃÄö½Ì
    • ½ÃÄö½Ì
    • µ¥ÀÌÅÍ ºÐ¼®

Á¦8Àå ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ¿ëµµº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Àü°Ô³ð ½ÃÄö½Ì
    • ´ë»ó ½ÃÄö½Ì
    • ¸ÞŸÀ¯ÀüüÇÐ
    • RNA ½ÃÄö½Ì
    • ¿¡ÇÇÁ¦³×ƽ½º
    • ±âŸ

Á¦9Àå ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Çмú¡¤¿¬±¸±â°ü
    • º´¿ø¡¤Å¬¸®´Ð
    • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • ±âŸ

Á¦10Àå ·Õ¸®µå ½ÃÄö½Ì ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ±â¼ú, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ¿öÅ©Ç÷οì, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ¿ëµµ, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾ ¿ëµµ, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ·Õ¸®µå ½ÃÄö½Ì ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Pacific Biosciences of California, Inc.
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
    • Oxford Nanopore Technologies Limited
    • Quantapore, Inc.
    • Element Biosciences
    • BGI Genomics
    • Eurofins Genomics
    • Stratos Genomics, Inc.
    • MicrobesNG
    • NextOmics
    • New England Biolabs

Á¦12Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç °¡Á¤
ksm 24.01.10

Global Long Read Sequencing Market is valued at approximately USD 455.1 million in 2022 and is anticipated to grow with a healthy growth rate of more than 30.92% over the forecast period 2023-2030. The Long Read Sequencing Market encompasses a range of products, services, and technologies dedicated to DNA sequencing methods capable of producing extended and contiguous sequences of genetic information, enabling in-depth analysis of genomes and other biological entities. It involves the development of long read sequencing platforms, instruments, reagents, and associated software solutions, driving advancements in genomics research, personalized medicine, and other applications in the life sciences field. The Long Read Sequencing Market is being driven by factors such as the increasing prevalence of chronic diseases and Increasing Applications in Clinical Diagnostics

Long Read Sequencing enables the generation of longer and contiguous DNA sequences, allowing for a more accurate and comprehensive analysis of the genome. This helps identify genetic variations, including rare or structural variants that are associated with chronic diseases such as diabetes, cardiovascular diseases, and cancer. According to American heart association, In 2020, the global prevalence of diabetes was 243.3 million males and 229.0 million females, while the economic burden of diabetes amounted to $1.3 trillion in 2015, projected to rise to $2.1 to $2.5 trillion by 2030. Moreover, the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Thus, the increasing economic burden of chronic diseases is fueling the growth of Long Read Sequencing Market. In addition, advancements in data analysis platforms and increasing applications in Whole Genome Sequencing create lucrative opportunities for the market. However, the high error rates of long read technology hinder the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Long Read Sequencing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the availability of a strong informatics network and well-established rules for the approval and marketing of genomic testing products and services. Asia Pacific is considered as the fastest growing region over the forecast period owing to increased investments in the development of state-of-the-art diagnostic techniques, alongside the expanding presence of major players aiming to capitalize on the opportunities.

Major market player included in this report are:

  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Limited
  • Quantapore, Inc.
  • Element Biosciences
  • BGI Genomics
  • Eurofins Genomics
  • Stratos Genomics, Inc.
  • MicrobesNG
  • NextOmics
  • New England Biolabs

Recent Developments in the Market:

  • In March 2023, Illumina introduced its advanced Illumina Complete Long Read Prep, a Human assay, designed specifically for performing high-performance whole-genome sequencing of human DNA. These would result in rising company's market share in the global market.

Global Long Read Sequencing Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Technology, Workflow, Application, End Use, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Instruments
  • Consumables
  • Services

By Technology:

  • Single Molecule Real Time Sequencing
  • Nanopore Sequencing
  • Others

By Workflow:

  • Pre-sequencing
  • Sequencing
  • Data Analysis

By Application:

  • Whole Genome Sequencing
  • Targeted Sequencing
  • Metagenomics
  • RNA Sequencing
  • Epigenetics
  • Others

By End Use:

  • Academic & Research Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Long Read Sequencing Market , by Region, 2020-2030 (USD Million)
    • 1.2.2. Long Read Sequencing Market , by Product, 2020-2030 (USD Million)
    • 1.2.3. Long Read Sequencing Market , by Technology, 2020-2030 (USD Million)
    • 1.2.4. Long Read Sequencing Market , by Workflow, 2020-2030 (USD Million)
    • 1.2.5. Long Read Sequencing Market , by Application, 2020-2030 (USD Million)
    • 1.2.6. Long Read Sequencing Market , by End Use, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Long Read Sequencing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Long Read Sequencing Market Dynamics

  • 3.1. Long Read Sequencing Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of chronic diseases
      • 3.1.1.2. Increasing Applications in Clinical Diagnostics
    • 3.1.2. Market Challenges
      • 3.1.2.1. High error rates of long read technologies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in data analysis platforms
      • 3.1.3.2. Rising application and demand in whole genome sequencing
      • 3.1.3.3. Rising technological advancement

Chapter 4. Global Long Read Sequencing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Long Read Sequencing Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Long Read Sequencing Market by Product, Performance - Potential Analysis
  • 5.3. Global Long Read Sequencing Market Estimates & Forecasts by Product 2020-2030 (USD Million)
  • 5.4. Long Read Sequencing Market , Sub Segment Analysis
    • 5.4.1. Instruments
    • 5.4.2. Consumables
    • 5.4.3. Services

Chapter 6. Global Long Read Sequencing Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Long Read Sequencing Market by Technology, Performance - Potential Analysis
  • 6.3. Global Long Read Sequencing Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
  • 6.4. Long Read Sequencing Market , Sub Segment Analysis
    • 6.4.1. Single Molecule Real Time Sequencing
    • 6.4.2. Nanopore Sequencing
    • 6.4.3. Others

Chapter 7. Global Long Read Sequencing Market, by Workflow

  • 7.1. Market Snapshot
  • 7.2. Global Long Read Sequencing Market by Workflow, Performance - Potential Analysis
  • 7.3. Global Long Read Sequencing Market Estimates & Forecasts by Workflow 2020-2030 (USD Million)
  • 7.4. Long Read Sequencing Market , Sub Segment Analysis
    • 7.4.1. Pre-sequencing
    • 7.4.2. Sequencing
    • 7.4.3. Data Analysis

Chapter 8. Global Long Read Sequencing Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Long Read Sequencing Market by Application, Performance - Potential Analysis
  • 8.3. Global Long Read Sequencing Market Estimates & Forecasts by Application 2020-2030 (USD Million)
  • 8.4. Long Read Sequencing Market , Sub Segment Analysis
    • 8.4.1. Whole Genome Sequencing
    • 8.4.2. Targeted Sequencing
    • 8.4.3. Metagenomics
    • 8.4.4. RNA Sequencing
    • 8.4.5. Epigenetics
    • 8.4.6. Others

Chapter 9. Global Long Read Sequencing Market, by End Use

  • 9.1. Market Snapshot
  • 9.2. Global Long Read Sequencing Market by End Use, Performance - Potential Analysis
  • 9.3. Global Long Read Sequencing Market Estimates & Forecasts by End Use 2020-2030 (USD Million)
  • 9.4. Long Read Sequencing Market , Sub Segment Analysis
    • 9.4.1. Academic & Research Institutes
    • 9.4.2. Hospitals & Clinics
    • 9.4.3. Pharmaceutical & Biotechnology Companies
    • 9.4.4. Others

Chapter 10. Global Long Read Sequencing Market, Regional Analysis

  • 10.1. Top Leading Countries
  • 10.2. Top Emerging Countries
  • 10.3. Long Read Sequencing Market , Regional Market Snapshot
  • 10.4. North America Long Read Sequencing Market
    • 10.4.1. U.S. Long Read Sequencing Market
      • 10.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 10.4.1.2. Technology breakdown estimates & forecasts, 2020-2030
      • 10.4.1.3. Workflow breakdown estimates & forecasts, 2020-2030
      • 10.4.1.4. Application breakdown estimates & forecasts, 2020-2030
      • 10.4.1.5. End Use breakdown estimates & forecasts, 2020-2030
    • 10.4.2. Canada Long Read Sequencing Market
  • 10.5. Europe Long Read Sequencing Market Snapshot
    • 10.5.1. U.K. Long Read Sequencing Market
    • 10.5.2. Germany Long Read Sequencing Market
    • 10.5.3. France Long Read Sequencing Market
    • 10.5.4. Spain Long Read Sequencing Market
    • 10.5.5. Italy Long Read Sequencing Market
    • 10.5.6. Rest of Europe Long Read Sequencing Market
  • 10.6. Asia-Pacific Long Read Sequencing Market Snapshot
    • 10.6.1. China Long Read Sequencing Market
    • 10.6.2. India Long Read Sequencing Market
    • 10.6.3. Japan Long Read Sequencing Market
    • 10.6.4. Australia Long Read Sequencing Market
    • 10.6.5. South Korea Long Read Sequencing Market
    • 10.6.6. Rest of Asia Pacific Long Read Sequencing Market
  • 10.7. Latin America Long Read Sequencing Market Snapshot
    • 10.7.1. Brazil Long Read Sequencing Market
    • 10.7.2. Mexico Long Read Sequencing Market
  • 10.8. Middle East & Africa Long Read Sequencing Market
    • 10.8.1. Saudi Arabia Long Read Sequencing Market
    • 10.8.2. South Africa Long Read Sequencing Market
    • 10.8.3. Rest of Middle East & Africa Long Read Sequencing Market

Chapter 11. Competitive Intelligence

  • 11.1. Key Company SWOT Analysis
    • 11.1.1. Company 1
    • 11.1.2. Company 2
    • 11.1.3. Company 3
  • 11.2. Top Market Strategies
  • 11.3. Company Profiles
    • 11.3.1. Pacific Biosciences of California, Inc.
      • 11.3.1.1. Key Information
      • 11.3.1.2. Overview
      • 11.3.1.3. Financial (Subject to Data Availability)
      • 11.3.1.4. Product Summary
      • 11.3.1.5. Recent Developments
    • 11.3.2. Oxford Nanopore Technologies Limited
    • 11.3.3. Quantapore, Inc.
    • 11.3.4. Element Biosciences
    • 11.3.5. BGI Genomics
    • 11.3.6. Eurofins Genomics
    • 11.3.7. Stratos Genomics, Inc.
    • 11.3.8. MicrobesNG
    • 11.3.9. NextOmics
    • 11.3.10. New England Biolabs

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦